Al Noor Hospitals Group PLC v Mediclinic International Limited (LM167Oct15) [2016] ZACT 9 (25 February 2016)

Al Noor Hospitals Group PLC v Mediclinic International Limited (LM167Oct15) [2016] ZACT 9 (25 February 2016)

The Tribunal found that although there is a horizontal overlap in the activities of Al Noor and Mediclinic in the provision of private healthcare services, there is no geographical overlap as Al Noor has no direct or indirect presence in South Africa. The proposed transaction would not alter the competitive structure of the market, and Mediclinic would continue to compete with other private hospitals. The transaction would not result in any changes to management, corporate structure, or BEE requirements in South Africa. No retrenchments or job losses were anticipated, and Mediclinic would retain its corporate head office in South Africa. The Tribunal concluded that the merger is unlikely...

Citation
[2016] ZACT 9
Parties
Applicant: Al Noor Hospitals Group PLC; Respondent: Mediclinic International Limited
Court
Competition Tribunal
Jurisdiction
South Africa
Judgment Date
25 February 2016
Case Number
LM167Oct15
Procedural Posture
Merger Application / Approval Hearing
Outcome
The proposed merger is approved unconditionally.
Judges
Yasmin Carrim, Medi Mokuena, Andiswa Ndoni
Legal Topics
Merger Control, Scheme of Arrangement, Public Interest, Horizontal Overlap
Competition Law Merger Control Scheme of Arrangement Public Interest Horizontal Overlap

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 3 Authorities cited 2 Party arguments 2
Sign in to unlock

Parties

Al Noor Hospitals Group PLC

Applicant

Mediclinic International Limited

Respondent

Procedural Posture

Merger Application / Approval Hearing

Legal Issues

  1. 1 Whether the proposed merger between Al Noor Hospitals Group PLC and Mediclinic International Limited is likely to substantially prevent or lessen competition in any relevant market.
  2. 2 Whether the transaction raises any public interest concerns under the Competition Act.

Ratio Decidendi

The Tribunal found that although there is a horizontal overlap in the activities of Al Noor and Mediclinic in the provision of private healthcare services, there is no geographical overlap as Al Noor has no direct or indirect presence in South Africa. The proposed transaction would not alter the competitive structure of the market, and Mediclinic would continue to compete with other private hospitals. The transaction would not result in any changes to management, corporate structure, or BEE requirements in South Africa. No retrenchments or job losses were anticipated, and Mediclinic would retain its corporate head office in South Africa. The Tribunal concluded that the merger is unlikely...

Court Disposition

The proposed merger is approved unconditionally.

Orders

  • The proposed transaction between Al Noor Hospitals Group PLC and Mediclinic International Limited is approved without conditions.